CritiSense
Givat Haim
About CritiSense
CritiSense was founded in 2004 on the basis of the assets of an earlier company named Vital Medical. The company's device, the Critiview, was developed by the company's co-founder and chief scientist, Professor Avraham Mayevsky, formerly head of the department of Department of Life Sciences and Dean of the Faculty of Natural Sciences at Bar Ilan University, where he established a center for tissue physiology. It provides continuous, real-time multi-parametric physiological data at the tissue and cellular level, by monitoring the mitochondrial function and the microcirculatory blood flow and oxygen saturation, by way of tissue titration therapy with an optical sensor.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $10K – $50K
- Total funding: $2.2M
- Last round: Series Unknown (Jun 2006)
- Website: critisense.com
- Phone: 97236354459
Industries & Categories
Biotechnology, Health Care
Social Profiles
Canonical: https://fsome.com/organization/critisense-3223934 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.